Sign up
Log in
12 Health Care Stocks Moving In Wednesday's Intraday Session
Share
Listen to the news

Gainers

  • AIM ImmunoTech (AMEX:AIM) shares moved upwards by 74.6% to $1.24 during Wednesday's regular session. The company's market cap stands at $2.8 million.
  • Artelo Biosciences (NASDAQ:ARTL) shares moved upwards by 29.48% to $6.28. The company's market cap stands at $9.7 million.
  • Mobile-health Network (NASDAQ:MNDR) shares moved upwards by 18.09% to $1.0. The market value of their outstanding shares is at $3.0 million. The company's, H1 earnings came out 4 days ago.
  • VolitionRX (AMEX:VNRX) shares increased by 17.84% to $0.22. The company's market cap stands at $25.7 million.
  • Regencell Bioscience (NASDAQ:RGC) stock rose 12.95% to $25.95. The market value of their outstanding shares is at $11.3 billion.
  • Ovid Therapeutics (NASDAQ:OVID) shares moved upwards by 12.85% to $2.27. The company's market cap stands at $143.1 million. The company's, Q4 earnings came out today.

Losers

  • Lunai Bioworks (NASDAQ:LNAI) shares declined by 31.3% to $0.38 during Wednesday's regular session. The market value of their outstanding shares is at $13.4 million.
  • Cingulate (NASDAQ:CING) stock decreased by 30.28% to $8.13. The company's market cap stands at $86.8 million. As per the press release, Q4 earnings came out today.
  • Akari Therapeutics (NASDAQ:AKTX) shares fell 24.31% to $0.16. The market value of their outstanding shares is at $7.7 million.
  • Gain Therapeutics (NASDAQ:GANX) stock declined by 23.86% to $2.0. The market value of their outstanding shares is at $100.7 million.
  • Cibus (NASDAQ:CBUS) shares declined by 20.11% to $2.94. The market value of their outstanding shares is at $243.0 million. As per the news, the Q4 earnings report came out yesterday.
  • Protalix BioTherapeutics (AMEX:PLX) stock decreased by 19.9% to $2.23. The company's market cap stands at $224.3 million. As per the press release, Q4 earnings came out today. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
English